Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to 13.94%.

  • Medical Group Holdings' EBITDA Margin fell 305600.0% to 13.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.67%, marking a year-over-year decrease of 74500.0%. This contributed to the annual value of 14.67% for FY2024, which is 9000.0% up from last year.
  • Latest data reveals that Medical Group Holdings reported EBITDA Margin of 13.94% as of Q3 2025, which was down 305600.0% from 25.52% recorded in Q2 2025.
  • Medical Group Holdings' 5-year EBITDA Margin high stood at 66.21% for Q1 2025, and its period low was 26.01% during Q4 2024.
  • In the last 3 years, Medical Group Holdings' EBITDA Margin had a median value of 17.91% in 2024 and averaged 22.99%.
  • As far as peak fluctuations go, Medical Group Holdings' EBITDA Margin crashed by -597200bps in 2024, and later surged by 504300bps in 2025.
  • Over the past 3 years, Medical Group Holdings' EBITDA Margin (Quarter) stood at 33.71% in 2023, then plummeted by -177bps to 26.01% in 2024, then skyrocketed by 154bps to 13.94% in 2025.
  • Its EBITDA Margin stands at 13.94% for Q3 2025, versus 25.52% for Q2 2025 and 66.21% for Q1 2025.